When the body loses weight, it normally reduces energy expenditure as a compensatory survival mechanism
Our focus is straightforward: provide high-purity materials, confirm identity and integrity through testing standards, and present products in a way that supports organized research workflows
Analytical consistency for 24 months Maintain structural integrity for 30 days Complete observation within 24 hours GHK-Cu is a naturally occurring copper-tripeptide (glycyl-L-histidyl-L-lysine bound to copper) first identified in human plasma in 1973
Food and Drug Administration, voted 8-6 with one abstention to place BPC-157 on the Section 503A Bulk Drug Substances List
Upregulation of LOX and LOXL2 has been implicated in several pathologies, including cancer, cardiac fibrosis, idiopathic pulmonary fibrosis, vascular stiffening in aging, and pulmonary hypertension 8,9,10,11,12,13,14